P Pu ur rp po os se e: : To evaluate the possible cost savings when routine preoperative testing is discontinued in ambulatory cataract surgery patients.
M Me et th ho od ds s: : A policy was introduced at our hospital to stop routine testing in ambulatory cataract patients. Consecutive patients' medical records were analyzed in a four-month period pre-and a fourmonth period post-discontinuation of routine laboratory tests. Ambulatory cataract surgery is performed under topical (and sometimes retrobulbar block) anesthesia with iv sedation. Co-morbidities, perioperative events, frequency and cost of tests ordered were compared for the two groups. Average costs per patient preand post-discontinuation of routine tests, and total possible cost savings were calculated.
R Re es su ul lt ts s: : One thousand two hundred and thirty-one patients were studied; 636 had routine laboratory tests and 595 had no routine laboratory tests. The ratios of gender, co-morbidities and perioperative events were similar in the two groups. There was a significant reduction in the number of tests ordered after the new policy was introduced, from 5.8 tests per patient to 0.4 tests per patient. The cost of tests per patient was reduced from Can $39.67 to $4.01.
C Co on nc cl lu us si io on n: : In ambulatory cataract surgery, over 90% savings in laboratory costs is possible after elimination of routine tests. To compare variables between the testing and nontesting groups, Student's t test was used for continuous data, and Chi-square test used for categorical data. P < 0.05 was considered statistically significant. R Re es su ul lt ts s The total number of cataract patients studied was 1,231; 636 consecutive patients in a four-month period in the year 2000 (testing group) and 595 consecutive patients to a similar period in the year 2001 (non-testing group). The ratios of male to female sex and ASA status were similar in both groups. There was no difference in the incidence or the severity of co-morbidities in the two groups. The outcomes evaluated were perioperative hypertension, hypotension, bradycardia arrhythmias, myocardial ischemia, myocardial infarction, congestive heart failure, syncope, hypoglycemia, oxygen saturation of less than 90%, and airway obstruction. There was no difference in the incidence of preoperative, intraoperative or postoperative events between the two groups (Table I) . Two cases were cancelled in the testing group, and none in the non-testing group. One of the cancellations was due to inadequate time, while the other was rescheduled because of an emergency case. There was one readmission in the testing group; the patient was admitted five days postoperatively because of endophthalmitis.
Objectif
There was, however, a significant reduction in the number of tests per patient ordered in the non-testing group, 0.4 tests per patient compared to 5.8 in the testing group (Table II) . Specifically, there were reductions in ordering of complete blood count (CBC), international normalized ratio/partial thromboplastin time, sickle cell screen, electrolytes, creatinine, urea, glucose, electrocardiogram in the non-testing group compared to the testing group. The cost per patient was $4.01 ± 18.92 in the nontesting group compared to $39.67 ± 19.04, in the testing group. A 90% reduction in laboratory costs per LFT = liver function test; ECG = electrocardiogram; ECHO = echocardiogram; CXR = chest x-ray; Pts, pt = patient(s); CBC = complete blood count; INR = international normalized ratio; PTT = partial thromboplastin time; ea = each; N/a = not applicable; Hb = hemoglobin. *P < 0.05 between testing non-testing groups.
Intraoperative events
patient was achieved. A potential cost savings of $21,217.7 was possible for the management of 595 patients [(39.67 -4.01) × 595]; 595 being a hypothetical number of patients in a four-month period.
There was also a reduction in the proportion of patients referred to the anesthesia consult clinic to 33% compared to 47% before the guidelines were introduced but this was not statistically significant.
D Di is sc cu us ss si io on n Routine tests are of little value in low risk ambulatory surgery. 1 Age alone should not be an indication for preoperative tests. 3 Other studies have found that when abnormalities are found in routine laboratory tests, surgery has rarely been delayed nor the anesthetic management changed. [4] [5] [6] [7] Kaplan et al. found that only 0.22% of routine tests done prior to elective surgery showed abnormalities that could have influenced perioperative management. 8 In our study there was no difference in perioperative morbidity between the two study groups (Table II) .
The main finding of our study was that 90% of the cost of testing can be potentially saved by stopping routine tests. There was a significant reduction in the number of tests ordered in the non-testing group, 0.4 tests per patient compared to 5.8 in the testing group. For example, despite a 10% prevalence of anemia in the elderly population, routine CBC is not warranted. 3 We reduced our CBC rate from 94% to 6%. The incidence of perioperative events in the Schein study was 3.1% whereas the incidence in our study was 0.79%.
Our study had no exclusion criteria and yet the findings were similar to that of Schein et al. 1 There was no difference in morbidity or mortality between the two groups.
The study has several limitations. Firstly, laboratory cost savings are calculated potential savings. Most of the cost incurred by the laboratory is for salary of personnel. With elimination of routine laboratory testing, cost savings are minimal and this potential in savings cannot be realized until the number of personnel required for testing can be reduced. Secondly, our data was collected retrospectively and this may have led to an underestimation of the frequency of adverse events. Thirdly, the relatively small number of patients studied is too small to conclude definitely on the risks of adverse events associated with the elimination of laboratory testing (risk of a type II error).
Lastly, extrapolating from our study results, a subset of low risk ambulatory surgical patients requiring only local anesthesia and sedation may not require routine preoperative tests. 9 However further study is required to establish the safety of this approach.
In summary, with ambulatory cataract surgery, over 90% savings in laboratory costs was possible after elimination of routine tests. Outcomes remained unchanged in this relatively small series of patients.
A Ac ck kn no ow wl le ed dg ge em me en nt ts s We acknowledge the cooperation and help of anesthesiologists and ophthalmologists at the Toronto Western Hospital, in making this study possible. We also thank Dajun Song and Tania DiRenna for their assistance in data collection and analyses. R Re ef fe er re en nc ce es s
